KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Short-term Investments (2016 - 2025)

Elevance Health (ELV) has disclosed Short-term Investments for 17 consecutive years, with $26.3 billion as the latest value for Q3 2025.

  • On a quarterly basis, Short-term Investments rose 2261.46% to $26.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $26.3 billion, a 2261.46% increase, with the full-year FY2024 number at $25.2 billion, up 10904.8% from a year prior.
  • Short-term Investments was $26.3 billion for Q3 2025 at Elevance Health, up from $25.3 billion in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $29.5 billion in Q1 2024 to a low of $165.0 million in Q3 2023.
  • A 5-year average of $15.6 billion and a median of $25.2 billion in 2024 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: plummeted 91.97% in 2021, then surged 10904.8% in 2024.
  • Elevance Health's Short-term Investments stood at $1.9 billion in 2021, then crashed by 49.34% to $953.0 million in 2022, then plummeted by 75.97% to $229.0 million in 2023, then soared by 10904.8% to $25.2 billion in 2024, then grew by 4.29% to $26.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Short-term Investments are $26.3 billion (Q3 2025), $25.3 billion (Q2 2025), and $25.4 billion (Q1 2025).